2022
Severe inpatient hypertension prevalence and blood pressure response to antihypertensive treatment
Ghazi L, Li F, Chen X, Simonov M, Yamamoto Y, Biswas A, Hanna J, Shah T, Townsend R, Peixoto A, Wilson FP. Severe inpatient hypertension prevalence and blood pressure response to antihypertensive treatment. Journal Of Clinical Hypertension 2022, 24: 339-349. PMID: 35174627, PMCID: PMC8925013, DOI: 10.1111/jch.14431.Peer-Reviewed Original ResearchConceptsSevere hypertensionBlood pressure responseBP elevationUntreated patientsCox proportional hazards modelRetrospective cohort studyPressure responseProportional hazards modelAntihypertensive treatmentInpatient hypertensionMore comorbiditiesPossible overtreatmentHospitalized adultsCohort studyHypertension prevalenceArterial pressureHospitalized patientsTreatment guidelinesHypertensionGreater rateHazards modelPatientsAntihypertensivesTreatmentAdmission
2019
Effect on Survival of Concurrent Hemoconcentration and Increase in Creatinine During Treatment of Acute Decompensated Heart Failure
Griffin M, Rao VS, Fleming J, Raghavendra P, Turner J, Mahoney D, Wettersten N, Maisel A, Ivey-Miranda JB, Inker L, Tang WHW, Wilson FP, Testani JM. Effect on Survival of Concurrent Hemoconcentration and Increase in Creatinine During Treatment of Acute Decompensated Heart Failure. The American Journal Of Cardiology 2019, 124: 1707-1711. PMID: 31601358, PMCID: PMC6959849, DOI: 10.1016/j.amjcard.2019.08.034.Peer-Reviewed Original ResearchConceptsAcute decompensated heart failureDecompensated heart failureHeart failureImproved survivalHigher loop diuretic dosesLoop diuretic dosesNet fluid lossPlasma volume reductionAggressive decongestionAggressive diuresisPostdischarge survivalDiuretic dosesPostdischarge outcomesSerum creatinineHospital treatmentHospital parametersBetter survivalCreatinineHemoconcentrationPatient carePatientsSurvivalLonger lengthVolume reductionTreatment
2015
Pharmacologic Treatment of Common Symptoms in Dialysis Patients: A Narrative Review
Moledina DG, Perry Wilson F. Pharmacologic Treatment of Common Symptoms in Dialysis Patients: A Narrative Review. Seminars In Dialysis 2015, 28: 377-383. PMID: 25913502, DOI: 10.1111/sdi.12378.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsTreatment of fatigueCommon symptomsEnd-stage renal disease patientsRenal disease patientsAnabolic steroid nandroloneDisease-related symptomsEvidence-based guidelinesEfficacy of drugsPharmacologic treatmentDialysis patientsCreatine supplementationDisease patientsTreatment decisionsHemodialysis experienceReduced qualityPatientsNarrative reviewSomatic symptomsSymptomsCrampsESRDTreatmentInsomniaTherapyHeavy burden
2014
Tumor Lysis Syndrome: New Challenges and Recent Advances
Wilson FP, Berns JS. Tumor Lysis Syndrome: New Challenges and Recent Advances. Advances In Kidney Disease And Health 2014, 21: 18-26. PMID: 24359983, PMCID: PMC4017246, DOI: 10.1053/j.ackd.2013.07.001.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsTumor lysis syndromeKidney failurePrevention of TLSTreatment of TLSUric acidClearance of potassiumLysis syndromeOncologic emergencyKidney manifestationsHematologic malignanciesRisk individualsMalignant cellsCancer typesPreventative effortsSecondary hypocalcemiaTreatmentHypocalcemiaHyperkalemiaHyperphosphatemiaFailureMalignancyPathophysiologyPathogenesisSyndromeEpidemiology
2012
Onco-Nephrology: Tumor Lysis Syndrome
Wilson FP, Berns JS. Onco-Nephrology: Tumor Lysis Syndrome. Clinical Journal Of The American Society Of Nephrology 2012, 7: 1730-1739. PMID: 22879434, DOI: 10.2215/cjn.03150312.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsTumor lysis syndromeLysis syndromeCancer cellsAcute myeloid leukemiaCytotoxic chemotherapyPrompt recognitionLymphoblastic leukemiaVolume repletionHematologic malignanciesMyeloid leukemiaBurkitt's lymphomaSecondary hypocalcemiaBlood streamHomeostatic mechanismsPatientsSyndromeLeukemiaTreatmentIntracellular contentHypocalcemiaCellsHyperkalemiaHyperphosphatemiaRasburicaseChemotherapy